M. L. Vegna
- Hematology top 1%
- Molecular Biology
- Oncology top 10%
- Genetics top 5%
- Pathology and Forensic Medicine top 10%
- Co-authors
- Franco MandelliGiuseppe AvvisatiM TribaltoSergio AmadoriMario BoccadoroFilippo MarmontAngela GernoneFranco Dammacco
- Topics
- Acute Myeloid Leukemia Research (13 papers)Acute Lymphoblastic Leukemia research (8 papers)Chronic Lymphocytic Leukemia Research (4 papers)
- Cited by
- HematologyGeneticsBiochemistry
- Partner nations
- ItalyFranceNetherlands
In The Last Decade
M. L. Vegna
20 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 53
- Hematology 765
- Molecular Biology 517
- Oncology 296
- Genetics 218
- Pathology and Forensic Medicine 186
Countries citing papers authored by M. L. Vegna
This map shows the geographic impact of M. L. Vegna's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. L. Vegna with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. L. Vegna more than expected).
Fields of papers citing papers by M. L. Vegna
This network shows the impact of papers produced by M. L. Vegna. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. L. Vegna. The network helps show where M. L. Vegna may publish in the future.
Co-authorship network of co-authors of M. L. Vegna
This figure shows the co-authorship network connecting the top 25 collaborators of M. L. Vegna. A scholar is included among the top collaborators of M. L. Vegna based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. L. Vegna. M. L. Vegna is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Fludarabine + prednisone +/- alpha-interferon followed or not by alpha-interferon maintenance therapy for previously untreated patients with chronic lymphocytic leukemia: long term results of a randomized study. | 3 |
| 2 | 104 | |
| 3 | 7 | |
| 4 | Autologous transplantation in multiple myeloma : a GITMO retrospective analysis on 290 patients | 24 |
| 5 | 143 | |
| 6 | 72 | |
| 7 | 13 | |
| 8 | 149 | |
| 9 | 95 | |
| 10 | Prognostic factors of patients with acute myeloid leukemia (AML) allografted in first complete remission: an analysis of the EORTC-GIMEMA AML 8A trial. The European Organization for Research and Treatment of Cancer (EORTC) and the Gruppo Italiano Malattie Ematologiche Maligne dell' Adulto (GIMEMA) Leukemia Cooperative Groups. | 55 |
| 11 | 20 | |
| 12 | Mitoxantrone, etoposide and intermediate-dose Ara-C (MEC): an effective regimen for poor risk acute myeloid leukemia. | 48 |
| 13 | 13 | |
| 14 | 42 | |
| 15 | 60 | |
| 16 | 24 | |
| 17 | 296 | |
| 18 | 2 | |
| 19 | 3 | |
| 20 | Intensification in post-remission treatment of adult acute non lymphocytic leukemia. | 2 |
About M. L. Vegna
M. L. Vegna is a scholar working on Hematology, Genetics and Public Health, Environmental and Occupational Health, having authored 20 papers that have together received 1.2k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (13 papers), Acute Lymphoblastic Leukemia research (8 papers) and Chronic Lymphocytic Leukemia Research (4 papers). The work is most often cited by research in Hematology (765 citations), Genetics (218 citations) and Biochemistry (73 citations). M. L. Vegna has collaborated with scholars based in Italy, France and Netherlands. Frequent co-authors include Franco Mandelli, Giuseppe Avvisati, M Tribalto, Sergio Amadori, Mario Boccadoro, Filippo Marmont, Angela Gernone, Franco Dammacco, Alessandro Pileri and Maria Teresa Petrucci. Their work appears in journals such as New England Journal of Medicine, Blood and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.